This MedLibrary.org supplementary page on Receptor-mediated endocytosis is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
Receptor-mediated endocytosis (RME), also called clathrin-dependent endocytosis, is a process by which cells internalize molecules (endocytosis) by the inward budding of plasma membrane vesicles containing proteins with receptor sites specific to the molecules being internalized.
Contents |
Process
After binding of a ligand to plasma membrane spanning receptors, a signal is sent through the membrane, leading to membrane coating, and formation of a membrane invagination. The receptor, its ligand, and anything nearby are then internalised in sub-micrometre sized clathrin-coated vesicles. Once internalised, the clathrin-coated vesicle uncoats (a pre-requisite for the vesicle to fuse with other membranes) and individual vesicles fuse to form the early endosome. Since the receptor is internalized with the ligand, the system is saturable and uptake will decline until receptors are recycled to the surface.
Function
The function of receptor-mediated endocytosis is diverse. Obviously it is widely used for the specific uptake of certain substances required by the cell (examples are the uptake of LDL via the LDL receptor or iron via transferrin). The role of receptor-mediated endocytosis is also well recognized in the downregulation of transmembrane signal transduction. The activated receptor becomes internalised and is transported to late endosomes and lysosomes for degradation. However, receptor-mediated endocytosis is also actively implicated in transducing signals from the cell periphery to the nucleus. This became apparent by the finding that the association and formation of specific signaling complexes is required for the effective signaling of hormones (e.g. EGF). Additionally it has been proposed that the directed transport of active signaling complexes to the nucleus might be required to enable signaling as random diffusion is too slow (Howe, 2005) and mechanisms permanently downregulating incoming signals are strong enough to shutdown signaling completely without additional signals transducing mechanisms (Kholodenko, 2003).
Experiments
Using fluorescent dyes to stain the plasma membrane, it is possible to follow the internalization of plasma membrane fragments by microscopy.
Since the process is non-specific, the ligand can be a carrier for larger molecules. If the target cell has a known, specific pinocytotic receptor, drugs can be attached and will be internalized. Cancer cells appear to have an overexpression of folate receptors, so super-toxic, banned drugs may be re-examined due to far less side effects in non-target tissue.
Specific Properties
- induction within minutes of exposure to excess ligand.
- the formation of these vesicles is sensitive to inhibition by wortmannin
- the initiation of vesicle formation can be delayed/inhibited by temperature variations
References
- Alberts, Bruce; et al. (2004). Essential Cell Biology, 2nd Edition, New York, NY: Garland Science. ISBN 0-8153-3480-X.
- Becker, Wayne (2005). World of the Cell. San Francisco: Benjamin Cummings. ISBN 0805346805.
- Howe, Charles L. (2005). "Modeling the Signaling Endosome Hypothesis: Why a Drive to the Nucleus Is Better Than a (Random) Walk". Theor. Biol. Med. Mod 2: 43. doi:. 2:43.
- Kholodenko, Boris N. (2003). "Four-Dimensional Organisation of Protein Kinase Signaling Cascades: the Roles of Diffusion, Endocytosis and Molecular Motors". J. Exp. Biol 206: 2073. doi:. PMID 12756289. 206, 2073-2082.
- Salazar MD, Ratnam M (Mar 2007). "The folate receptor: what does it promise in tissue-targeted therapeutics?". Cancer Metastasis Rev. 26 (1): 141–52. doi:. PMID 17333345.
See also
|
|||||||||||
External links
- CytoChemistry.net- A lecture on RME with some nice pictures
 |
This cell biology article is a stub. You can help Wikipedia by expanding it. |
Wikipedia content modification information:
- This page was last modified on 15 October 2008, at 15:44.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Receptor-mediated endocytosis".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.